Study of Personalized Cancer Therapy to Determine Response and Toxicity
NCT02478931
·
clinicaltrials.gov ↗
RECRUITING
Status
10000
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Sponsor
Shu Mei Kato